远视市场-全球及区域分析：依国家及地区-分析与预测（2025-2035年）

远视是眼睛的屈光不正，俗称远视。

进入眼睛的光线聚焦在视网膜后方，而不是直接聚焦在视网膜上，导致近处物体模糊，远处物体清晰。远视通常是由眼球过短或角膜曲率不足引起的。远视可能是先天性的，严重程度不一。远视的症状包括阅读困难、眼睛疲劳、头痛和近距离视力模糊。远视通常可以透过配戴眼镜、隐形眼镜或屈光矫正手术（例如LASIK）来矫正。

远视市场的主要驱动力之一是人口老化。随着老龄化，眼睛自然聚焦于近处物体的能力会下降，导致一种与远视密切相关的疾病——老花眼。随着全球人口老化，远视和老花眼的发病率正在上升，从而增加了对视力矫正解决方案的需求。此外，智慧型手机、电脑和平板电脑等数位装置的使用增加，导致了数位眼疲劳，从而加剧了远视症状。这进一步增加了对眼镜、隐形眼镜和先进的雷射视力矫正术的需求，从而推动了远视市场的显着成长。此外，人们对可用治疗方法的认识不断提高以及眼镜技术的进步也有助于扩大市场机会。

儘管远视市场正在成长，但仍有许多挑战阻碍其发展。主要挑战之一是高昂的治疗费用，尤其是雷射眼科手术（例如LASIK和 PRK）和高端隐形眼镜等先进解决方案。虽然这些治疗方案能够带来长期益处，但前期成本对许多患者来说可能是一个障碍，尤其是在新兴市场和缺乏全面医疗保险的个人。此外，缺乏对现有治疗方法和定期眼科检查需求的了解往往会导致诊断延误，从而引发併发症并加重远视。另一个挑战是患者由于担心安全性、潜在副作用或手术风险而不愿接受手术介入。最后，虽然眼镜和隐形眼镜是常见的解决方案，但它们并非永久性解决方案，许多患者需要持续维护和频繁更换，这可能会造成长期沉重的负担。

全球远视市场竞争激烈，几个主要企业推动创新和市场成长。依视路、艾伯维 (Allergan)、博士伦、爱尔康、库博、Orasis Pharmaceuticals 和再生元製药等公司处于提供尖端远视治疗和视力矫正解决方案的前沿。依视路凭藉广泛的眼镜和镜片产品组合占据市场主导地位，提供专为远视定制的高清和渐进镜片。艾伯维 (Allergan) 推出了 Vuity，一种治疗老花眼（一种与远视相关的疾病）的新型药物。博士伦透过博士伦提供隐形眼镜和雷射手术技术，而爱尔康则专注于先进的LASIK和隐形眼镜。库博公司旗下的 CooperVision 品牌专营隐形眼镜，并提供高品质的远视解决方案。 Orasis Pharmaceuticals 正在开发 CSF-1 等前景光明的药物疗法，用于非手术治疗老花眼和远视。 Regeneron Pharmaceuticals 以其眼科疾病研究而闻名，同时也致力于影响更广泛的眼科护理市场。这些公司在开发创新产品和治疗方法处于行业领先地位，提供多种有效治疗远视的选择，并满足日益增长的视力矫正解决方案需求。

市场区隔:

细分一：按地区

• 北美洲
• 欧洲
• 亚太地区

全球远视市场正经历重大变革时期，其驱动力源自于重塑远视管理和治疗方法的新兴趋势。推动这项转型的关键因素包括LASIK和PRK等雷射手术技术的进步，这些技术正变得更加精准、创伤更小、应用范围更广。这些创新使得远视手术治疗更方便有效，恢復时间更短，成功率更高。

此外，为了满足不断变化的个人需求，尤其是应对长时间使用萤幕导致的数位眼睛疲劳，智慧眼镜产品和自我调整镜片的日益普及也推动了市场需求的转变。各公司也专注于个人化视力矫正解决方案，提供客製化隐形眼镜和高清眼镜，为远视患者提供舒适和精准的配镜体验。老花眼（一种常与远视相关的疾病）眼药水等药物治疗的兴起，透过提供非手术视力矫正选择，进一步推动了市场成长。人们日益增强的眼部健康意识，以及防蓝光镜片和多焦点隐形眼镜等经济实惠的解决方案的兴起，也促进了市场的扩张。总的来说，这些趋势正在改变远视市场，使治疗更有效、更便捷，并为更广泛的消费者提供个人化服务。

本报告研究了全球远视市场，并提供了市场概述以及特定国家和地区的趋势和公司概况。

目录

执行摘要

第一章 全球远视市场：产业展望

• 介绍
• 市场趋势
• 法律规范
• 流行病学分析
• 临床试验分析
• 市场动态

第 2 章。 2023 年至 2035 年全球远视市场（按地区）

• 北美洲
• 欧洲

第三章全球远视市场：竞争格局与公司概况

• 关键策略和发展
  • 合併与收购
  • 协同活动
  • 业务扩展和资金筹措
  • 产品发布和核准
  • 其他活动
• 公司简介
  • Essilor Luxottica
  • AbbVie Inc. (Allergan)
  • Bausch Health Companies Inc.
  • Alcon Inc.
  • The Cooper Companies Inc.
  • Orasis Pharmaceuticals
  • Regeneron Pharmaceuticals

第四章调查方法

Global Hyperopia Market, Analysis and Forecast: 2025-2035

Hyperopia is a refractive error in the eye, commonly known as farsightedness. It occurs when light entering the eye is focused behind the retina rather than directly on it, making nearby objects appear blurred while distant objects are seen more clearly. Hyperopia is often caused by the eye being too short or the cornea having insufficient curvature. The condition can be present from birth, and its severity can vary. Symptoms of hyperopia may include difficulty reading, eye strain, headaches, and blurred vision for close-up tasks. It is typically corrected with glasses, contact lenses, or refractive surgeries like LASIK to help focus light properly onto the retina.

One of the key drivers of the Hyperopia market is the aging population. As people age, the natural ability of the eye to focus on close objects diminishes, a condition known as presbyopia, which is closely related to hyperopia. With the global population aging, the incidence of hyperopia and presbyopia is increasing, leading to a higher demand for vision correction solutions. Additionally, the growing use of digital devices like smartphones, computers, and tablets is contributing to digital eye strain, which exacerbates the symptoms of hyperopia. This has further fueled the demand for glasses, contact lenses, and advanced laser vision correction procedures, driving significant growth in the hyperopia market. The increasing awareness of available treatments and advancements in eyewear technology also play a role in expanding market opportunities.

Despite the growth of the Hyperopia market, several challenges continue to hinder its progress. One of the primary challenges is the high cost of treatments, particularly for advanced solutions like laser eye surgeries (such as LASIK or PRK) and premium contact lenses. While these treatments can offer long-term benefits, the initial cost can be a barrier for many patients, especially in emerging markets or for individuals without comprehensive health insurance coverage. Additionally, the lack of awareness about available treatments and the need for regular eye exams often results in delayed diagnosis, which can lead to complications or worsening of hyperopia. Another challenge is the patient resistance to surgical interventions due to concerns about safety, potential side effects, or the perceived risks of surgery. Lastly, while eyeglasses and contact lenses are common solutions, they do not provide a permanent fix, and many individuals require ongoing maintenance or frequent replacements, which can be a significant burden over time.

The global Hyperopia market is highly competitive, with several leading companies driving innovation and market growth. Companies such as Essilor Luxottica, AbbVie Inc. (Allergan), Bausch Health Companies Inc., Alcon Inc., The Cooper Companies Inc., Orasis Pharmaceuticals, and Regeneron Pharmaceuticals are at the forefront of providing cutting-edge solutions for hyperopia treatment and vision correction. Essilor Luxottica dominates the market with its extensive portfolio of eyewear and lenses, offering high-definition lenses and progressive lenses tailored for hyperopia. AbbVie (Allergan) has introduced Vuity, a novel pharmacologic treatment for presbyopia, a condition related to hyperopia. Bausch Health, through its Bausch + Lomb division, provides both contact lenses and laser surgery technologies, while Alcon focuses on advanced LASIK and contact lenses. The Cooper Companies Inc., with its CooperVision brand, specializes in contact lenses, offering high-quality solutions for hyperopia. Orasis Pharmaceuticals is developing promising pharmaceutical treatments like CSF-1 to treat presbyopia and hyperopia non-surgically. Regeneron Pharmaceuticals, although known for its work in ocular diseases, is also positioned to influence the broader eye care market. These companies are leading the way in developing innovative products and therapies, offering a wide range of options to effectively treat hyperopia and meet the growing demand for vision correction solutions.

Market Segmentation:

Segmentation 1: by Region

• North America
• Europe
• Asia-Pacific

The global Hyperopia market is undergoing significant transformation, fueled by emerging trends that are reshaping the way hyperopia is managed and treated. Key drivers of this transformation include advancements in laser surgery technologies like LASIK and PRK, which are becoming more precise, less invasive, and more widely available. These innovations are making surgical treatments for hyperopia more accessible and effective, with quicker recovery times and higher success rates.

Additionally, the increasing adoption of smart eyewear and adaptive lenses that cater to the changing needs of individuals, especially in the context of digital eye strain caused by prolonged screen time, is contributing to a shift in market demand. Companies are also focusing on personalized vision correction solutions, offering customized contact lenses and high-definition eyeglasses that provide greater comfort and precision for individuals with hyperopia. The rise in pharmaceutical treatments, such as eye drops for presbyopia (a condition often linked to hyperopia), is further driving market growth by providing non-surgical alternatives for vision correction. The growing awareness of eye health and the increasing availability of affordable solutions, including blue light-blocking lenses and multifocal contact lenses, are also contributing to the expanding market. These trends are collectively transforming the hyperopia market, making treatments more effective, accessible, and personalized for a wider range of consumers.

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Analysis and Forecast Note

1. Global Hyperopia Market: Industry Outlook

• 1.1 Introduction
• 1.2 Market Trends
• 1.3 Regulatory Framework
• 1.4 Epidemiology Analysis
• 1.5 Clinical Trial Analysis
• 1.6 Market Dynamics
  • 1.6.1 Impact Analysis
  • 1.6.2 Market Drivers
  • 1.6.3 Market Challenges
  • 1.6.4 Market Opportunities

2. Global Hyperopia Market (Region), ($Billion), 2023-2035

• 2.1 North America
  • 2.1.1 Key Findings
  • 2.1.2 Market Dynamics
  • 2.1.3 Market Sizing and Forecast
    • 2.1.3.1 North America Hyperopia Market, by Country
      • 2.1.3.1.1 U.S.
• 2.2 Europe
  • 2.2.1 Key Findings
  • 2.2.2 Market Dynamics
  • 2.2.3 Market Sizing and Forecast
    • 2.2.3.1 Europe Hyperopia Market, by Country
      • 2.2.3.1.1 Germany
      • 2.2.3.1.2 U.K.
      • 2.2.3.1.3 France
      • 2.2.3.1.4 Italy
• 2.3 Asia Pacific
  • 2.3.1 Key Findings
  • 2.3.2 Market Dynamics
  • 2.3.3 Market Sizing and Forecast
    • 2.3.3.1 Asia Pacific Hyperopia Market, by Country
      • 2.3.3.1.1 China
      • 2.3.3.1.2 Japan

3. Global Hyperopia Market: Competitive Landscape and Company Profiles

• 3.1 Key Strategies and Development
  • 3.1.1 Mergers and Acquisitions
  • 3.1.2 Synergistic Activities
  • 3.1.3 Business Expansions and Funding
  • 3.1.4 Product Launches and Approvals
  • 3.1.5 Other Activities
• 3.2 Company Profiles
  • 3.2.1 Essilor Luxottica
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products / Product Portfolio
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Target Customers/End-Users
    • 3.2.1.5 Key Personnel
    • 3.2.1.6 Analyst View
  • 3.2.2 AbbVie Inc. (Allergan)
    • 3.2.2.1 Overview
    • 3.2.2.2 Top Products / Product Portfolio
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Target Customers/End-Users
    • 3.2.2.5 Key Personnel
    • 3.2.2.6 Analyst View
  • 3.2.3 Bausch Health Companies Inc.
    • 3.2.3.1 Overview
    • 3.2.3.2 Top Products / Product Portfolio
    • 3.2.3.3 Top Competitors
    • 3.2.3.4 Target Customers/End-Users
    • 3.2.3.5 Key Personnel
    • 3.2.3.6 Analyst View
  • 3.2.4 Alcon Inc.
    • 3.2.4.1 Overview
    • 3.2.4.2 Top Products / Product Portfolio
    • 3.2.4.3 Top Competitors
    • 3.2.4.4 Target Customers/End-Users
    • 3.2.4.5 Key Personnel
    • 3.2.4.6 Analyst View
  • 3.2.5 The Cooper Companies Inc.
    • 3.2.5.1 Overview
    • 3.2.5.2 Top Products / Product Portfolio
    • 3.2.5.3 Top Competitors
    • 3.2.5.4 Target Customers/End-Users
    • 3.2.5.5 Key Personnel
    • 3.2.5.6 Analyst View
  • 3.2.6 Orasis Pharmaceuticals
    • 3.2.6.1 Overview
    • 3.2.6.2 Top Products / Product Portfolio
    • 3.2.6.3 Top Competitors
    • 3.2.6.4 Target Customers/End-Users
    • 3.2.6.5 Key Personnel
  • 3.2.7 Regeneron Pharmaceuticals
    • 3.2.7.1 Overview
    • 3.2.7.2 Top Products / Product Portfolio
    • 3.2.7.3 Top Competitors
    • 3.2.7.4 Target Customers/End-Users
    • 3.2.7.5 Key Personnel
    • 3.2.7.6 Analyst View

4. Research Methodology

List of Figures

• Figure: Global Hyperopia Market (by Region), $Billion, 2024 and 2035
• Figure: Global Hyperopia Market Key Trends, Analysis

List of Tables

• Table: Global Hyperopia Market Dynamics, Impact Analysis
• Table: Global Hyperopia Market (by Region), $Billion, 2024-2035